A phase 1/2 study of REGN7075 (EGFRxCD28 costimulatory bispecific antibody) in combination with cemiplimab (anti–PD-1) in patients with advanced solid tumors, including colorectal cancer: Trial in progress update
Segal, Neil Howard ; Girda, Eugenia ; Sohal, Davendra ; Lakhani, Nehal J. ; Olszanski, Anthony J. ; Fong, Lawrence ; Han, Hyunsil ; Casey, Kerry A. ; Li, Siyu ; Ganguly, Samit ; Seebach, Frank A. ; Mathias, Melissa Divya ; Pelster, Meredith
Journal of clinical oncology, 2024-01, Vol.42 (3_suppl), p.TPS239-TPS239 [Periódico revisado por pares]Sem texto completo